Market news Latest

Creative Biolabs Releases a Series of Cell Products for CAR-T Therapy

 Breaking News
  • No posts were found

Creative Biolabs Releases a Series of Cell Products for CAR-T Therapy

March 31
07:30 2020

New York, USA – As a professional antibody expert, Creative Biolabs, specialized in the novel immunotherapy development for years, especially in Chimeric antigen receptor T cell therapy (CAR-T) field, provides a comprehensive list of cell products for CAR-T development projects, including but not limited to immune cell products, jurkat cell products.

Chimeric antigen receptor T cell therapy (CAR-T) is known as the most efficient method for the treatment of various diseases. It’s an intricate process that involves a wide variety of factors and requires advanced technology platforms.

To meet global client’s different needs, Creative Biolabs has established a comprehensive platform that not only covers the entire CAR-T therapy development process from biomarker identification to clinical trial but also enables a high-quality production of cell products.

Creative Biolabs develops plenty of immune cell products including PBMC, T cells, B cells, NK cells, DCs, and stem cells, and Jurkat cell products to facilitate clients’ CAR-T projects, characterized by the FcγRIII genotype. For immune cells, Neutrophils from 3 donors, Monocyte Derived Dendritic Cells from 5 donors and various types of Mouse Cells are available. For Jurkat Cell Products, Creative Biolabs provides a series of antigen targets for TCR and CAR.

Features:

1. Cell counting, vitality and functional testing have been performed
2. Purification and characterization by flow cytometry
3. HLA type (if available)

“The quality control is our top priority. Based on our exclusive technologies, we can meet distinct needs from either academic researchers or immunologists, and guarantee the purity, viability and function of our cells,” said the manager at Creative Biolabs.

As a world-renowned service provider for immunotherapy, Creative Biolabs is equipped with a large collection of CAR products of different generations targeting various biomarkers, and the Ph.D. level scientist has insisted on innovating the next generation CAR technologies to accelerate the CAR-T field.

More information can be reached at https://www.creative-biolabs.com/car-t.

About Creative Biolabs

Creative Biolabs was founded by scientists who are dedicated to the treatment of a wide variety of diseases, including immune disorders, cancers, infections and more. Over the last 10 years, Creative Biolabs has becoming a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. The cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.creative-biolabs.com/car-t